Fredag 8 Maj | 13:57:07 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2027-02-26 08:00 Bokslutskommuniké 2026
2026-10-20 08:00 Kvartalsrapport 2026-Q3
2026-07-21 08:00 Kvartalsrapport 2026-Q2
2026-06-26 N/A Årsstämma
2026-05-08 N/A X-dag ordinarie utdelning PTRK 0.00 SEK
2026-04-23 - Kvartalsrapport 2026-Q1
2026-02-27 - Bokslutskommuniké 2025
2025-10-21 - Kvartalsrapport 2025-Q3
2025-07-24 - Kvartalsrapport 2025-Q2
2025-06-30 - X-dag ordinarie utdelning PTRK 0.00 SEK
2025-06-27 - Årsstämma
2025-05-13 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-12 - Kvartalsrapport 2024-Q3
2024-08-13 - Kvartalsrapport 2024-Q2
2024-05-14 - Kvartalsrapport 2024-Q1
2024-05-06 - X-dag ordinarie utdelning PTRK 0.00 SEK
2024-05-03 - Årsstämma
2024-02-29 - Bokslutskommuniké 2023
2023-11-14 - Kvartalsrapport 2023-Q3
2023-08-15 - Kvartalsrapport 2023-Q2
2023-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2023-05-03 - Årsstämma
2023-05-02 - Kvartalsrapport 2023-Q1
2023-02-28 - Bokslutskommuniké 2022
2022-11-07 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-05-26 - Kvartalsrapport 2022-Q1
2022-05-04 - X-dag ordinarie utdelning PTRK 0.00 SEK
2022-05-03 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-10-20 - Kvartalsrapport 2021-Q3
2021-07-28 - Kvartalsrapport 2021-Q2

Beskrivning

LandStorbritannien
ListaFirst North Stockholm
SektorInformationsteknik
IndustriProgramvara
Physitrack är verksamt inom hälsovårdssektorn och specialiserat inom sjukgymnastik. Produktportföljen inkluderar digitala vårderbjudanden till företag via SaaS-lösningar. Utöver huvudverksamheten erbjuds även personlig service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa och Nordamerika. Physitrack grundades år 2012 och har sitt huvudkontor i London.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-05-08 11:30:00

This Notice of General Meeting is an important document and requires your immediate attention. If you are in any doubt as to what action to take, you should consult your stockbroker, bank manager, solicitor, accountant and/or other appropriate independent professional advisers without delay.

If you sold or otherwise transferred all of your shares in the Company, please send this Notice, together with the accompanying documents, immediately to the purchaser or transferee or to the person who had arranged the sale or transfer, so they can pass these documents to the person who now holds the shares.
Notice is hereby given that a General Meeting of Physitrack PLC will be held at We Are Club, 73 Rue du Faubourg Saint-Honoré, 75008 Paris, France on Tuesday, 26 May 2026 at 10.30am CET/9.30am BST (or, if the Company's 2026 Annual General Meeting convened for 9.30am CET/8.30am BST on the same day and at the same venue has not been declared closed by 10.30am CET/9.30am BST, commencing immediately following the close of the AGM), for the following purpose:
To consider and, if thought fit, pass the following resolution, proposed as a Special Resolution. For this resolution to be passed, at least three-quarters of the votes cast must be in favour.

Special Resolution
That the amount of €24,935,421 standing to the credit of the Company's share premium account be cancelled.



Background to and reasons for the Capital Reduction
The Company currently has a share premium account of €24,935,421. This account is a non-distributable reserve under the Companies Act 2006, meaning it cannot, for example, be used to pay dividends or fund market purchases of the Company's own shares.
The Board is proposing to cancel the share premium account in order to create distributable reserves to facilitate market purchases of the Company's own shares (as previously disclosed), as well as for other corporate purposes.
The Capital Reduction will not involve any distribution or return of capital to shareholders and will not reduce the Company's underlying assets. It will not affect the rights attaching to the Ordinary Shares and will not result in any change to the number of Ordinary Shares in issue or their nominal value.
The Capital Reduction requires both shareholder approval (by special resolution) and confirmation by the High Court of England and Wales. Accordingly, if the resolution is passed at the General Meeting, an application will be made to the Court to confirm and approve the Capital Reduction. Subject to shareholder and Court approval, the Capital Reduction is expected to become effective in July 2026.



Voting
Shareholders may vote on the resolution as follows:

Proxy votes must be received by no later than 8:30am (UK time) on 21 May 2026.
The Circular, Notice of General Meeting and Postal Voting Form have today been published on the Company's website at www.physitrackgroup.com.